Pieris Pharmaceuticals, Inc.

  • Home
  • About
  • Platform
  • Pipeline
  • Patients
  • Investors
    • Overview
    • News & Events
    • Presentations
    • Financial Results
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
    • Job Openings
  • Contact
  • News & Events

  • Overview
  • Press Releases
  • Media
  • Publications
  • IR Calendar
  • Email Alerts
Jan 10, 2011 12:00am EST

Takeda San Francisco and Pieris Sign Anticalin® Therapeutic Collaboration

Sep 28, 2010 12:00am EDT

Pieris Signs Broad Collaboration with Sanofi-Aventis and Sanofi Pasteur to Develop Anticalin Therapeutics

Jun 15, 2010 12:00am EDT

Pieris Initiates Phase I Clinical Trial for Lead Anticalin Compound

Jun 07, 2010 12:00am EDT

Pieris AG Appoints Chief Scientific Officer

Apr 30, 2010 12:00am EDT

Pieris Announces Positive Preclinical Data on c-Met Anticalin Drug Program

Jan 04, 2010 12:00am EST

Pieris Appoints a New CEO

Oct 09, 2009 12:00am EDT

Pieris reports preclinical development progress of its next generation VEGF antagonist

Sep 15, 2009 12:00am EDT

Pieris AG enters into Anticalin Collaboration with Allergan, Inc.

Feb 03, 2009 12:00am EST

Pieris reports development progress for Anticalin® PRS-050, a next generation VEGF antagonist

Jul 16, 2008 12:00am EDT

Wacker validates scalability of Anticalin® production with E.coli secretion technology and will produce Pieris first clinical candidate PRS-050

  • Previous
  • 1…
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2022 Pieris Pharmaceuticals, Inc. All Rights Reserved.
Imprint Privacy Policy Disclaimer Sitemap Contact Us Manage Cookie Preferences